Your browser doesn't support javascript.
loading
Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial.
Mulder, E E A P; de Joode, K; Litière, S; Ten Tije, A J; Suijkerbuijk, K P M; Boers-Sonderen, M J; Hospers, G A P; de Groot, J W B; van den Eertwegh, A J M; Aarts, M J B; Piersma, D; van Rijn, R S; Kapiteijn, E; Vreugdenhil, G; van den Berkmortel, F W P J; Hoop, E Oomen-de; Franken, M G; Ryll, B; Rutkowski, P; Sleijfer, S; Haanen, J B A G; van der Veldt, A A M.
Afiliação
  • Mulder EEAP; Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, The Netherlands.
  • de Joode K; Department of Surgical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, The Netherlands.
  • Litière S; Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, The Netherlands.
  • Ten Tije AJ; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
  • Suijkerbuijk KPM; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands.
  • Boers-Sonderen MJ; Department of Medical Oncology, University Medical Centre Utrecht Cancer Centre, Utrecht, The Netherlands.
  • Hospers GAP; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • de Groot JWB; Department of Medical Oncology, University Medical Centre Groningen, Groningen, The Netherlands.
  • van den Eertwegh AJM; Department of Medical Oncology, Isala Oncological Centre, Zwolle, The Netherlands.
  • Aarts MJB; Department of Medical Oncology, Amsterdam University Medical Centre - location VU, Amsterdam, The Netherlands.
  • Piersma D; Department of Medical Oncology, Maastricht University Medical Centre +, Maastricht, The Netherlands.
  • van Rijn RS; Department of Internal Medicine, Medisch Spectrum Twente, Enschede, The Netherlands.
  • Kapiteijn E; Department of Internal Medicine, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.
  • Vreugdenhil G; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands.
  • van den Berkmortel FWPJ; Department of Internal Medicine, Máxima Medical Centre, Veldhoven, The Netherlands.
  • Hoop EO; Department of Internal Medicine, Zuyderland Medical Centre, Sittard-Geleen, The Netherlands.
  • Franken MG; Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, The Netherlands.
  • Ryll B; Institute for Medical Technology Assessment, Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
  • Rutkowski P; Melanoma Patient Network Europe, Uppsala, Sweden.
  • Sleijfer S; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Haanen JBAG; Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, The Netherlands.
  • van der Veldt AAM; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
BMC Cancer ; 21(1): 323, 2021 Mar 25.
Article em En | MEDLINE | ID: mdl-33765967
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Suspensão de Tratamento / Receptor de Morte Celular Programada 1 / Inibidores de Checkpoint Imunológico / Melanoma Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Qualitative_research Limite: Adult / Female / Humans / Male Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Suspensão de Tratamento / Receptor de Morte Celular Programada 1 / Inibidores de Checkpoint Imunológico / Melanoma Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Qualitative_research Limite: Adult / Female / Humans / Male Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda